
The global market for Non-invasive Continuous Glucose Monitor was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Non-invasive Continuous Glucose Monitor, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Non-invasive Continuous Glucose Monitor by region & country, by Type, and by Application.
The Non-invasive Continuous Glucose Monitor market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-invasive Continuous Glucose Monitor.
Market Segmentation
By Company
Dexcom
Abbott Laboratories
Medtronic
Senseonics Holdings
Know Labs
Huzhou Meiqi Medical Devices
San Meditech
Roche
LifeScan, Inc.
Insulet Corporation
Panasonic
Echo Therapeutics
Tandem Diabetes Care
Segment by Type:
Wearable
Not wearable
Segment by Application
Hospital
Clinic
Other
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Non-invasive Continuous Glucose Monitor manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Non-invasive Continuous Glucose Monitor in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Non-invasive Continuous Glucose Monitor in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Market Overview
1.1 Non-invasive Continuous Glucose Monitor Product Introduction
1.2 Global Non-invasive Continuous Glucose Monitor Market Size Forecast
1.2.1 Global Non-invasive Continuous Glucose Monitor Sales Value (2019-2030)
1.2.2 Global Non-invasive Continuous Glucose Monitor Sales Volume (2019-2030)
1.2.3 Global Non-invasive Continuous Glucose Monitor Sales Price (2019-2030)
1.3 Non-invasive Continuous Glucose Monitor Market Trends & Drivers
1.3.1 Non-invasive Continuous Glucose Monitor Industry Trends
1.3.2 Non-invasive Continuous Glucose Monitor Market Drivers & Opportunity
1.3.3 Non-invasive Continuous Glucose Monitor Market Challenges
1.3.4 Non-invasive Continuous Glucose Monitor Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Non-invasive Continuous Glucose Monitor Players Revenue Ranking (2023)
2.2 Global Non-invasive Continuous Glucose Monitor Revenue by Company (2019-2024)
2.3 Global Non-invasive Continuous Glucose Monitor Players Sales Volume Ranking (2023)
2.4 Global Non-invasive Continuous Glucose Monitor Sales Volume by Company Players (2019-2024)
2.5 Global Non-invasive Continuous Glucose Monitor Average Price by Company (2019-2024)
2.6 Key Manufacturers Non-invasive Continuous Glucose Monitor Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Non-invasive Continuous Glucose Monitor Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Non-invasive Continuous Glucose Monitor
2.9 Non-invasive Continuous Glucose Monitor Market Competitive Analysis
2.9.1 Non-invasive Continuous Glucose Monitor Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Non-invasive Continuous Glucose Monitor Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-invasive Continuous Glucose Monitor as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Wearable
3.1.2 Not wearable
3.2 Global Non-invasive Continuous Glucose Monitor Sales Value by Type
3.2.1 Global Non-invasive Continuous Glucose Monitor Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Non-invasive Continuous Glucose Monitor Sales Value, by Type (2019-2030)
3.2.3 Global Non-invasive Continuous Glucose Monitor Sales Value, by Type (%) (2019-2030)
3.3 Global Non-invasive Continuous Glucose Monitor Sales Volume by Type
3.3.1 Global Non-invasive Continuous Glucose Monitor Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Non-invasive Continuous Glucose Monitor Sales Volume, by Type (2019-2030)
3.3.3 Global Non-invasive Continuous Glucose Monitor Sales Volume, by Type (%) (2019-2030)
3.4 Global Non-invasive Continuous Glucose Monitor Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Other
4.2 Global Non-invasive Continuous Glucose Monitor Sales Value by Application
4.2.1 Global Non-invasive Continuous Glucose Monitor Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Non-invasive Continuous Glucose Monitor Sales Value, by Application (2019-2030)
4.2.3 Global Non-invasive Continuous Glucose Monitor Sales Value, by Application (%) (2019-2030)
4.3 Global Non-invasive Continuous Glucose Monitor Sales Volume by Application
4.3.1 Global Non-invasive Continuous Glucose Monitor Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Non-invasive Continuous Glucose Monitor Sales Volume, by Application (2019-2030)
4.3.3 Global Non-invasive Continuous Glucose Monitor Sales Volume, by Application (%) (2019-2030)
4.4 Global Non-invasive Continuous Glucose Monitor Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Non-invasive Continuous Glucose Monitor Sales Value by Region
5.1.1 Global Non-invasive Continuous Glucose Monitor Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Non-invasive Continuous Glucose Monitor Sales Value by Region (2019-2024)
5.1.3 Global Non-invasive Continuous Glucose Monitor Sales Value by Region (2025-2030)
5.1.4 Global Non-invasive Continuous Glucose Monitor Sales Value by Region (%), (2019-2030)
5.2 Global Non-invasive Continuous Glucose Monitor Sales Volume by Region
5.2.1 Global Non-invasive Continuous Glucose Monitor Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Non-invasive Continuous Glucose Monitor Sales Volume by Region (2019-2024)
5.2.3 Global Non-invasive Continuous Glucose Monitor Sales Volume by Region (2025-2030)
5.2.4 Global Non-invasive Continuous Glucose Monitor Sales Volume by Region (%), (2019-2030)
5.3 Global Non-invasive Continuous Glucose Monitor Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Non-invasive Continuous Glucose Monitor Sales Value, 2019-2030
5.4.2 North America Non-invasive Continuous Glucose Monitor Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Non-invasive Continuous Glucose Monitor Sales Value, 2019-2030
5.5.2 Europe Non-invasive Continuous Glucose Monitor Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Non-invasive Continuous Glucose Monitor Sales Value, 2019-2030
5.6.2 Asia Pacific Non-invasive Continuous Glucose Monitor Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Non-invasive Continuous Glucose Monitor Sales Value, 2019-2030
5.7.2 South America Non-invasive Continuous Glucose Monitor Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Non-invasive Continuous Glucose Monitor Sales Value, 2019-2030
5.8.2 Middle East & Africa Non-invasive Continuous Glucose Monitor Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Non-invasive Continuous Glucose Monitor Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Non-invasive Continuous Glucose Monitor Sales Value
6.2.1 Key Countries/Regions Non-invasive Continuous Glucose Monitor Sales Value, 2019-2030
6.2.2 Key Countries/Regions Non-invasive Continuous Glucose Monitor Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Non-invasive Continuous Glucose Monitor Sales Value, 2019-2030
6.3.2 United States Non-invasive Continuous Glucose Monitor Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Non-invasive Continuous Glucose Monitor Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Non-invasive Continuous Glucose Monitor Sales Value, 2019-2030
6.4.2 Europe Non-invasive Continuous Glucose Monitor Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Non-invasive Continuous Glucose Monitor Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Non-invasive Continuous Glucose Monitor Sales Value, 2019-2030
6.5.2 China Non-invasive Continuous Glucose Monitor Sales Value by Type (%), 2023 VS 2030
6.5.3 China Non-invasive Continuous Glucose Monitor Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Non-invasive Continuous Glucose Monitor Sales Value, 2019-2030
6.6.2 Japan Non-invasive Continuous Glucose Monitor Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Non-invasive Continuous Glucose Monitor Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Non-invasive Continuous Glucose Monitor Sales Value, 2019-2030
6.7.2 South Korea Non-invasive Continuous Glucose Monitor Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Non-invasive Continuous Glucose Monitor Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Non-invasive Continuous Glucose Monitor Sales Value, 2019-2030
6.8.2 Southeast Asia Non-invasive Continuous Glucose Monitor Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Non-invasive Continuous Glucose Monitor Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Non-invasive Continuous Glucose Monitor Sales Value, 2019-2030
6.9.2 India Non-invasive Continuous Glucose Monitor Sales Value by Type (%), 2023 VS 2030
6.9.3 India Non-invasive Continuous Glucose Monitor Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Dexcom
7.1.1 Dexcom Company Information
7.1.2 Dexcom Introduction and Business Overview
7.1.3 Dexcom Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Dexcom Non-invasive Continuous Glucose Monitor Product Offerings
7.1.5 Dexcom Recent Development
7.2 Abbott Laboratories
7.2.1 Abbott Laboratories Company Information
7.2.2 Abbott Laboratories Introduction and Business Overview
7.2.3 Abbott Laboratories Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Abbott Laboratories Non-invasive Continuous Glucose Monitor Product Offerings
7.2.5 Abbott Laboratories Recent Development
7.3 Medtronic
7.3.1 Medtronic Company Information
7.3.2 Medtronic Introduction and Business Overview
7.3.3 Medtronic Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Medtronic Non-invasive Continuous Glucose Monitor Product Offerings
7.3.5 Medtronic Recent Development
7.4 Senseonics Holdings
7.4.1 Senseonics Holdings Company Information
7.4.2 Senseonics Holdings Introduction and Business Overview
7.4.3 Senseonics Holdings Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Senseonics Holdings Non-invasive Continuous Glucose Monitor Product Offerings
7.4.5 Senseonics Holdings Recent Development
7.5 Know Labs
7.5.1 Know Labs Company Information
7.5.2 Know Labs Introduction and Business Overview
7.5.3 Know Labs Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Know Labs Non-invasive Continuous Glucose Monitor Product Offerings
7.5.5 Know Labs Recent Development
7.6 Huzhou Meiqi Medical Devices
7.6.1 Huzhou Meiqi Medical Devices Company Information
7.6.2 Huzhou Meiqi Medical Devices Introduction and Business Overview
7.6.3 Huzhou Meiqi Medical Devices Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Huzhou Meiqi Medical Devices Non-invasive Continuous Glucose Monitor Product Offerings
7.6.5 Huzhou Meiqi Medical Devices Recent Development
7.7 San Meditech
7.7.1 San Meditech Company Information
7.7.2 San Meditech Introduction and Business Overview
7.7.3 San Meditech Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2019-2024)
7.7.4 San Meditech Non-invasive Continuous Glucose Monitor Product Offerings
7.7.5 San Meditech Recent Development
7.8 Roche
7.8.1 Roche Company Information
7.8.2 Roche Introduction and Business Overview
7.8.3 Roche Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Roche Non-invasive Continuous Glucose Monitor Product Offerings
7.8.5 Roche Recent Development
7.9 LifeScan, Inc.
7.9.1 LifeScan, Inc. Company Information
7.9.2 LifeScan, Inc. Introduction and Business Overview
7.9.3 LifeScan, Inc. Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2019-2024)
7.9.4 LifeScan, Inc. Non-invasive Continuous Glucose Monitor Product Offerings
7.9.5 LifeScan, Inc. Recent Development
7.10 Insulet Corporation
7.10.1 Insulet Corporation Company Information
7.10.2 Insulet Corporation Introduction and Business Overview
7.10.3 Insulet Corporation Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Insulet Corporation Non-invasive Continuous Glucose Monitor Product Offerings
7.10.5 Insulet Corporation Recent Development
7.11 Panasonic
7.11.1 Panasonic Company Information
7.11.2 Panasonic Introduction and Business Overview
7.11.3 Panasonic Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Panasonic Non-invasive Continuous Glucose Monitor Product Offerings
7.11.5 Panasonic Recent Development
7.12 Echo Therapeutics
7.12.1 Echo Therapeutics Company Information
7.12.2 Echo Therapeutics Introduction and Business Overview
7.12.3 Echo Therapeutics Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Echo Therapeutics Non-invasive Continuous Glucose Monitor Product Offerings
7.12.5 Echo Therapeutics Recent Development
7.13 Tandem Diabetes Care
7.13.1 Tandem Diabetes Care Company Information
7.13.2 Tandem Diabetes Care Introduction and Business Overview
7.13.3 Tandem Diabetes Care Non-invasive Continuous Glucose Monitor Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Tandem Diabetes Care Non-invasive Continuous Glucose Monitor Product Offerings
7.13.5 Tandem Diabetes Care Recent Development
8 Industry Chain Analysis
8.1 Non-invasive Continuous Glucose Monitor Industrial Chain
8.2 Non-invasive Continuous Glucose Monitor Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Non-invasive Continuous Glucose Monitor Sales Model
8.5.2 Sales Channel
8.5.3 Non-invasive Continuous Glucose Monitor Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
Dexcom
Abbott Laboratories
Medtronic
Senseonics Holdings
Know Labs
Huzhou Meiqi Medical Devices
San Meditech
Roche
LifeScan, Inc.
Insulet Corporation
Panasonic
Echo Therapeutics
Tandem Diabetes Care
Ìý
Ìý
*If Applicable.
